Company: JBI
Filing Date: 2025-04-10
Form Type: PRE 14A
Source: 0001140361-25-013248
Chunk: 5

Company: Janus International Group, Inc.
Filing Date: 2025-04-10
Form: PRE 14A
Chunk 5
---
 |     | Director                             |     |     2023 |     |    2027 |     |            |     | Yes         |

Corporate Governance Highlights We are committed to strong corporate governance practices and policies, as described below, that support effective Board leadership and prudent management practices.

| • | Robust risk oversight by the full Board and its committees. |

| • | Annual review of key Committee charters and Corporate Governance Guidelines. The charters of each of these committees can be viewed on Janus’s investor website. |

| • | Independent Audit, Compensation, and Nominating and Corporate Governance Committees. |

| • | Annual Board and Committee self-evaluations. |

| • | Limits on memberships on other public company boards of directors. |

| • | Active recruitment of qualified, diverse director candidates. |

| • | Oversight of our code of ethics. |

| • | Policy concerning ongoing educational resources and opportunities related to fiduciary duties and other matters. |

2

TABLE OF CONTENTS

| • | Insider Trading Policy applicable to directors, executive officers, and other Company individuals, including prohibitions against short sales, hedging, margin accounts, and pledging. |

| • | Clawback Policy provides for the recoupment of certain executive compensation in the event that the Company is required to prepare an accounting restatement of its financial statements due to material noncompliance with any financial reporting requirement under the securities laws. |

| • | Separation of roles of Chair of the Board (the “Chair”) and CEO. |

| • | Eight of our nine directors are independent, including our Chair. |

| • | Proposed annual advisory vote to approve executive compensation. |

| • | Director participation in Board and committee meetings during 2024 for all incumbent directors was 75% or more during the period for which each director served on the Board or each such committee during 2024. |

| • | No poison pill. |

| • | Whistleblowing procedures and strict non-retaliation policy. |

| • | Meaningful stock ownership guidelines for directors and executives. |

Executive Compensation Preview The “Executive and Director Compensation” section of this Proxy Statement provides a discussion of our executive compensation philosophy and the pay programs applicable to our named executive officers. Our compensation program design links compensation to the performance of our business and rewards fiscal year results through our annual incentive plan and long-term performance with equity awards. Our Named Executive Officers Our leadership team during fiscal year 2024 included the following named executive officers (“NEOs